Not Medicare Enrolled

Alexis Fitzgerald, PA-C

Medical Physician Assistant · Irving, TX
1141 KINWEST PKWY STE 100, Irving, TX 75063
2142392222
Registered in NPPES since 2021
NPI: 1629656186 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Fitzgerald from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Fitzgerald? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Fitzgerald

Alexis Fitzgerald is a medical physician assistant in Irving, TX, with 5 years of NPI registration.

Between the years covered by Open Payments, Fitzgerald received a total of $5,254 from 27 pharmaceutical and/or device companies across 222 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Fitzgerald is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 5 years of NPI registration $5,254 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,254
Total received (2021-2024)
Avg $1,314/year across 4 years
Top 11% in TX for medical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
222
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$820
2023
$1,122
2022
$1,115
2021
$2,197

Payments by company (2024)

Boehringer Ingelheim Pharmaceuticals, Inc.
$211
Novo Nordisk Inc
$174
Phathom Pharmaceuticals, Inc.
$91
GlaxoSmithKline, LLC.
$69
Lilly USA, LLC
$66
PFIZER INC.
$39
Exact Sciences Corporation
$34
AstraZeneca Pharmaceuticals LP
$32
ABBVIE INC.
$30
Currax Pharmaceuticals LLC
$29
Phadia US Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Avvisto Therapeutics, LLC
$15
Top 3 companies account for 57.9% of 2024 payments
All-time payments by company (2021-2024) ›
Biohaven Pharmaceuticals, Inc.
$1,291
Boehringer Ingelheim Pharmaceuticals, Inc.
$715
AstraZeneca Pharmaceuticals LP
$620
Novo Nordisk Inc
$550
GlaxoSmithKline, LLC.
$488
Lilly USA, LLC
$357
PFIZER INC.
$215
ABBVIE INC.
$163
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$142
Astellas Pharma US Inc
$94
Phathom Pharmaceuticals, Inc.
$91
Amarin Pharma Inc.
$84
Biohaven Pharmaceutical Holding Company Ltd.
$68
Exact Sciences Corporation
$67
Merck Sharp & Dohme LLC
$47
IDORSIA PHARMACEUTICALS US INC
$42
Althera Pharmaceuticals LLC
$39
Merck Sharp & Dohme Corporation
$32
Currax Pharmaceuticals LLC
$29
AbbVie Inc.
$26
Phadia US Inc.
$16
Paratek Pharmaceuticals, Inc.
$15
Avvisto Therapeutics, LLC
$15
Janssen Pharmaceuticals, Inc
$13
Arbor Pharmaceuticals, Inc.
$13
VistaPharm, Inc.
$12
Kowa Pharmaceuticals America, Inc.
$11
Top 3 companies account for 50.0% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · AIRSUPRA · AREXVY · BELSOMRA · BREZTRI · CONTRAVE · CYCLOSET · Cologuard Collection Kit · EMGALITY · Edarbyclor · FARXIGA · GARDASIL 9 · ImmunoCAP · JARDIANCE · LINZESS · Livalo · MOUNJARO · NURTEC ODT · NUZYRA · Ozempic · PREMARIN · PREVNAR 13 · PREVNAR 20 · QULIPTA · QUVIVIQ · Roszet · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · Saxenda · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Thyquidity · UBRELVY · VOQUEZNA · VRAYLAR · Vascepa · Wegovy · XARELTO · XIFAXAN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical physician assistant in Irving?
Compare medical physician assistants in the Irving area by procedure volume, costs, and industry payment transparency.
Browse medical physician assistants nearby

Geographic Context

Medical physician assistants in nearby ZIP areas
541
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR SURGICAL HOSPITAL AT LAS COLINAS
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Fitzgerald is a medical physician assistant.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Fitzgerald receive payments from pharmaceutical companies?
Yes. Fitzgerald received a total of $5,254 from 27 companies across 222 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Fitzgerald) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →